# GAIN THERAPEUTICS INC (GANX) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 36269B105
Page URL: https://superinvestorclub.com/stock/GANX
Last updated: 2026-08-29T13:45:49.353Z

## Summary

As of the most recent 13F filing period, GAIN THERAPEUTICS INC (GANX) is held by 1 tracked superinvestors with an aggregate position value of $1.1M representing 0566130 shares.

## Top institutional holders (1)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [David Einhorn](https://superinvestorclub.com/manager/5) | Greenlight Capital | 566130 | $1.1M | 0.03% | 2026-06-30 |

## Ownership history (quarter-over-quarter)

- 2021-09-30: 1 holders, $4.1M aggregate, 0546560 shares
- 2021-12-31: 1 holders, $3.0M aggregate, 0546560 shares
- 2022-03-31: 1 holders, $2.2M aggregate, 0546560 shares
- 2022-06-30: 1 holders, $2.0M aggregate, 0546560 shares
- 2022-09-30: 1 holders, $1.8M aggregate, 0546560 shares
- 2022-12-31: 1 holders, $1.7M aggregate, 0546560 shares
- 2023-03-31: 1 holders, $2.6M aggregate, 0546560 shares
- 2023-06-30: 1 holders, $2.4M aggregate, 0546560 shares
- 2023-09-30: 1 holders, $1.9M aggregate, 0588410 shares
- 2023-12-31: 1 holders, $1.9M aggregate, 0588410 shares
- 2024-03-31: 1 holders, $2.1M aggregate, 0566130 shares
- 2024-06-30: 1 holders, $724,646 aggregate, 0566130 shares

## Recent congressional trades (0)


## Recent insider transactions (0)


## Citation

When citing, use: "GAIN THERAPEUTICS INC (GANX) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/GANX), aggregating SEC 13F, Form 4, and congressional disclosures."